In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID. New research ...

Multisystem inflammatory syndromes in children represent a rare but serious post-infectious hyperinflammatory condition most notably observed in association with SARS-CoV-2. Clinically, affected ...

Study reveals a mechanism behind multisystem inflammatory syndrome in children (MIS-C). Early in the COVID-19 pandemic, some children fought off COVID with few, if any, symptoms, only to go into organ ...

A number of pediatric hospitals across the country are warning about an increase in the number of cases of multi-system inflammatory syndrome in children, a rare condition in which different parts of ...

Scientists have found a potential cause of multisystem inflammatory syndrome in children (MIS-C) linked to SARS-CoV-2 (COVID) infections. St. Jude Children's Research Hospital scientists have ...

MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was ...

St. Jude Children's Research Hospital scientists have identified a link between a SARS-CoV-2 protein and the onset of multisystem inflammatory syndrome in children (MIS-C). MIS-C is a pediatric ...

Faster resolution of GI symptoms, faster clearance of spike antigen, faster return to usual activities reported for children treated with larazotide. HealthDay News — Treatment of multisystem ...

Some children who had COVID developed a severe inflammatory response that could put them in the ICU. Scientists have learned why it happens. It’s one of the enduring mysteries of the pandemic: What ...

RNA is expelled from cells via cell death or active release, and can then find its way into blood plasma. Medical researchers have now developed machine learning models that use these cell-free ...